1Hagensee ME;Koutsky LA;Lee SK.Detection of cervical antibodies to human papillomavirus type 16(HPV-16)capsid antigens in relation to detection of HPV-16 DNA and cervical lesions[J],2000(04).
2Yoshida T;Sano T;Kanuma T.Immunochemical analysis of HPV LI capsid protein and p16 protein in liquid-based cytology samples from uterine cervical lesions[J],2008(02).
4Petry KU;Menton S;Menton M.Inclusion of HPV testing in routine cervical cancer screening for women above 29 years in Germany:result for 8466 patients,2003(10).
6McNally OM;Mulvany NJ;Pagano R.VIN3 a clinicopathologic review[J],2002(05).
7Castellsagué X.Natural history and epidemiology of HPV infection and cervical cancer Suppl,2008(32).
8Smith JS;Lindsay L;Hoots B.Human papillomavirus type distribution in invasive cervical cancer and high-grade cervical lesions:a meta-analysis update[J],2007(03).
10Shi JF;Belinson JL;Zhao FH.Human papillomavirus testing for cervicalcancer screening:results from a 6-year prospective study in rural China[J],2009(06).
5Usuda H, Saito T, Emura I, et al. Immunohistochemistry of cyclin D3 in pulmonary carcinomas. Virchows Arch, 1996, 428 (3) :159-163.
6Baay MF, Weyler J, Vermorken JB, et al. The value of human papillomavirus detection in primary cervical cancer screening. Eur J Gynaecol 0ncol,2004, 25 (6) :665-669.
7Chao A, Lin CT, Hsueh S, et, al. Usefulness of human papillomavirus testing in the follow-up of patients with high-grade cervical intraepithelial neoplasia after conization. Am J Obstet Gyneeol, 2004, 190(4) :1046-1051.
8Li J, Li LK, Ma JF, et al. Knowledge and attitudes about hunmn papillomavirus (HPV) and HPV vaccines among women living in metropolitan and rural regions of China. Vaccine, 2009, 27 ( 8 ) : 1210-1215.
